JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v5i4.2476 jpsim.v5i4.2476 Original Research Deep Vein Thrombosis in Stroke Patients Presenting to Lady Reading Hospital Peshawar Khan Muhammad Sohail Bilal Muhammad drmba@yahoo.com * Saba Rubina Khattak Saima Khan Yaseen Fareezuddin Mian Lady Reading Hospital Peshawar Federal Public Service Commission, Pakistan. *Correspondence: Muhammad Bilal (drmba@yahoo.com) 09 12 2024 2024 5 4 740 744 16 02 2024 01 11 2024 Copyright © 2024 The Author(s) 2024 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective

The purpose of this study was to ascertain whether stroke patients and deep vein thrombosis were related.

 Methodology

The general medicine department of Lady Reading Hospital in Peshawar is where this descriptive case series study was carried out. The study was carried out between July 15, 2020, and January 15, 2021. The study included a total of 225 stroke patients of all genders. On the fourteenth day after the stroke, a doppler ultrasound was conducted to check for deep vein thrombosis in all of the patients. According to the operational definition, deep vein thrombosis was observed.

 Results

The study encompassed a 30- to 70-year-old age span, with a mean age of 56.6±7.1 years and a mean weight of 83.8±7.1 kg. 60% of male patients had a stroke, 59.6% had hemorrhagic strokes, and 40.4% had strokes. Ten percent of the patients had deep vein thrombosis.

 Conclusion

Patients with higher weights, males, and adults (30–50 years old) were more likely to get deep vein thrombosis. Furthermore, patients with hemorrhagic stroke showed a significant increase in Deep Vein Thrombosis. A prospective investigation comprising further examinations is required to determine the frequency of DVT in stroke patients as well as the pertinent risk variables.

 Keywords Stroke Hemorrhagic Ischemic Deep Vein Thrombosis Ethics Statement

Ethics committee: Ethics Committee, Lady Reading Hospital MTI, Peshawar, Pakistan. Approval number: 480/LRH/MTI, dated 16-06-2020.

 References Feigin, V.L., et al., World Stroke Organization (WSO): global stroke fact sheet 2022. International Journal of Stroke, 2022. 17(1): p. 18-29. Nakajima, M., et al., Asymptomatic deep venous thrombosis identified on routine screening in patients with hospitalized neurological diseases. Journal of Clinical Neuroscience, 2022. 102: p. 13-20. Tornyos, D., et al., Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials. Plos one, 2022. 17(8): p. e0273103. CRASH, T., Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. The Lancet, 2019. 394(10210): p. 1713-1723. Georgakis, M.K. and D. Gill, Mendelian randomization studies in stroke: exploration of risk factors and drug targets with human genetic data. Stroke, 2021. 52(9): p. 2992-3003. Bembenek, J., et al., Early stroke-related deep venous thrombosis: risk factors and influence on outcome. Journal of thrombosis and thrombolysis, 2011. 32: p. 96-102. Pastori, D., et al., A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. International Journal of Molecular Sciences, 2023. 24(4): p. 3169. Soriano-Tárraga, C., et al., Biological age is a predictor of mortality in ischemic stroke. Scientific reports, 2018. 8(1): p. 4148. Langhorne, P., et al., Stroke systems of care in high-income countries: what is optimal? The Lancet, 2020. 396(10260): p. 1433-1442. Moussaddy, A., A.M. Demchuk, and M.D. Hill, Thrombolytic therapies for ischemic stroke: Triumphs and future challenges. Neuropharmacology, 2018. 134: p. 272-279. Ziaka, M. and A. Exadaktylos, The Heart Is at Risk: Understanding Stroke-Heart-Brain Interactions with Focus on Neurogenic Stress Cardiomyopathy—A Review. Journal of stroke, 2023. 25(1): p. 39-54. Krinock, M.J. and N.S. Singhal, Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia. Annals of the New York Academy of Sciences, 2021. 1495(1): p. 78-98. Marko, M., et al., Trends of r-tPA (recombinant tissue-type plasminogen activator) treatment and treatment-influencing factors in acute ischemic stroke. Stroke, 2020. 51(4): p. 1240-1247. Chamorro, Á., et al., The future of neuroprotection in stroke. Journal of Neurology, Neurosurgery & Psychiatry, 2021. 92(2): p. 129-135. Savvina, I.A. and A.O. Petrova, The Treatment of Acute Stroke, in Ischemic Stroke. 2020, IntechOpen. p. 85. Owen, B., et al., Incidence and outcomes of intracerebral haemorrhage with mechanical compression hydrocephalus. Stroke and Vascular Neurology, 2021. 6(3). Ajam, T., et al., Non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation: safety issues in the elderly. Expert Review of Clinical Pharmacology, 2020. 13(12): p. 1309-1327. Tan, S.S., et al., Early deep vein thrombosis: incidence in Asian stroke patients. ANNALS-ACADEMY OF MEDICINE SINGAPORE, 2007. 36(10): p. 815. Kawase, K., et al., Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage. Cerebrovascular diseases, 2009. 27(4): p. 313-319. Kelly, J., et al., Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke, 2004. 35(10): p. 2320-2325. De Silva, D.A., et al., Deep vein thrombosis following ischemic stroke among Asians. Cerebrovascular Diseases, 2006. 22(4): p. 245-250. Holst, A.G., G. Jensen, and E. Prescott, Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation, 2010. 121(17): p. 1896-1903. Liu, L.P., et al., Risk assessment of deep‐vein thrombosis after acute stroke: a prospective study using clinical factors. CNS neuroscience & therapeutics, 2014. 20(5): p. 403-410. Rinde, L.B., et al., Ischemic stroke and risk of venous thromboembolism in the general population: the Tromsø study. Journal of the American Heart Association, 2016. 5(11): p. e004311. Kujovich, J.L., Hormones and pregnancy: thromboembolic risks for women. British journal of haematology, 2004. 126(4): p. 443-454. Miller, J., B.K. Chan, and H.D. Nelson, Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the US Preventive Services Task Force. Annals of internal medicine, 2002. 136(9): p. 680-690. Severinsen, M.T., et al., Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation, 2009. 120(19): p. 1850-1857. Delluc, A., et al., Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study. Journal of Thrombosis and Haemostasis, 2009. 7(4): p. 728-729. Pomp, E.R., et al., Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British journal of haematology, 2007. 139(2): p. 289-296. Heit, J.A., et al., Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Archives of internal medicine, 2002. 162(11): p. 1245-1248. Liu, X.-c., et al., Anatomical distribution of lower-extremity deep venous thrombosis in patients with acute stroke. Journal of Stroke and Cerebrovascular Diseases, 2020. 29(7): p. 104866.